If your Chael Sonnen, you are probably wishing this drug saga would just go away.
MMAFighting.com reported on Saturday night that Sonnen failed a second drug test that was administered by the Nevada State Athletic Commission to him on June 5 in his home state of Oregon. Sonnen tested positive for human growth hormone, recombinant human erythropoietin, anastrozole and human chorionic gonadotropin.
When this second test was given to Sonnen, the first drug test results were not revealed yet. Those results were revealed to the world on June 10, which forced Sonnen to bow out of his UFC 175 fight this coming Saturday with Vitor Belfort. The following day, Sonnen retired from the sport.
Sonnen released a statement to MMAFighting confirming the second drug test failure.
“Yes, the Commission is aware of other prescribed medications I was taking and I will not challenge their allegations,” Sonnen stated. “I will cooperate with the Commission and look forward to having a dialogue about how fighters who transition off TRT can avoid violating any rules.”
People were awaiting a response from the UFC and the company released a statement following UFC Fight Night 44 on Saturday.
“We were made aware that a second random test, conducted earlier this month, resulted in a positive test for additional banned substances,” said a statement read by Dave Sholler, the UFC’s Senior Director of Public Relations, at the post-event news conference for UFC Fight Night 44 in San Antonio. “Chael will have the opportunity to appear in front of the Nevada athletic commission next month, and through a statement released to media tonight, he’s pledged to cooperate.
“Our stance on the subject remains absolutely the same: We support the commission and we will continue to ensure that all UFC competitors compete on an even playing field, free of performance-enhancing drugs and banned substances.”
Sonnen will have a hearing later this year with the Nevada Commission regarding the drug test failures.